India: GSK establishes Global Drug Development Support Centre With Tata Consultancy Services

GlaxoSmithKline (GSK) and Tata Consultancy Services announced an agreement to establish a global drug development support centre in Mumbai to help meet the demands of the growing GSK pipeline.

Under a multi-year multi-million dollar contract agreed by the two companies, TCS will provide a variety of services in clinical research, including clinical data management and clinical submissions support.

The partnership will help GSK expand capacity in response to increased efficiency demands, leverage the high-quality talent pool in India, and benefit from cost and process improvements.

The centre will house a TCS team of highly skilled professionals including pharmacologists, PhDs in life sciences, post-graduates in Pharmacy, and individuals with a life sciences background experienced in clinical-data management and programming.

TCS will bring in its strong domain expertise, superior talent management skills, flexible operating models, proven transition capabilities and performance driven processes.

GSK, whose presence in India dates from 1924, is the leading research-based pharmaceutical company in the country by sales. The pharmaceuticals business of GSK India employs 2,425 people.

The Life Sciences and Healthcare Practice at TCS has over 3200 professionals including pharmacologists, physicians, biomedical engineers, biostatisticians, ICH/GCP compliance professionals, GxP consultants, PhDs, IT architects, consultants and management graduates who are focused on providing best in class IT consulting, solutions and services to Life Sciences and Healthcare customers across the world.